Anti-Müllerian hormone as an ovarian reserve marker in young cancer women who undergo ovarian tissue cryopreservation.

AIM To evaluate if anti-Müllerian hormone (AMH) is a reliable marker of ovarian reserve in young women undergoing ovarian tissue cryopreservation. PATIENTS & METHODS Relationships of serum AMH levels with primordial follicle density, age and reproductive hormones were investigated using the Pearson or Spearman correlation coefficient in 86 women with cancer (12-38 years) undergoing ovarian tissue cryopreservation. AMH variations through the menstrual cycle were assessed by the Kruskal-Wallis test. p < 0.05 was accepted as significant. RESULTS AMH positively correlated with primordial follicle density (p = 0.03), showed great interindividual variability at all ages and negatively correlated with estradiol (p = 0.007) in the early follicular phase. AMH did not vary across the menstrual cycle (p = 0.415). CONCLUSION AMH appears a valid ovarian reserve marker in young cancer women.

[1]  N. Raine-Fenning,et al.  Intracycle variation in number of antral follicles stratified by size and in endocrine markers of ovarian reserve in women with normal ovulatory menstrual cycles , 2013, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[2]  R. Anderson.  What does anti‐Müllerian hormone tell you about ovarian function? , 2012, Clinical endocrinology.

[3]  I. Schipper,et al.  Serum anti-müllerian hormone levels in healthy females: a nomogram ranging from infancy to adulthood. , 2012, The Journal of clinical endocrinology and metabolism.

[4]  R. Fanchin,et al.  Differential regulation of ovarian anti-müllerian hormone (AMH) by estradiol through α- and β-estrogen receptors. , 2012, The Journal of clinical endocrinology and metabolism.

[5]  K. Main,et al.  Individual serum levels of anti-Müllerian hormone in healthy girls persist through childhood and adolescence: a longitudinal cohort study. , 2012, Human reproduction.

[6]  K. Main,et al.  Serum levels of anti-Müllerian hormone as a marker of ovarian function in 926 healthy females from birth to adulthood and in 172 Turner syndrome patients. , 2010, The Journal of clinical endocrinology and metabolism.

[7]  F. Broekmans,et al.  The antral follicle count: practical recommendations for better standardization. , 2010, Fertility and sterility.

[8]  S. Nakajima,et al.  Müllerian-inhibiting substance inhibits cytochrome P450 aromatase activity in human granulosa lutein cell culture. , 2008, Fertility and sterility.

[9]  D. Seifer,et al.  Mullerian Inhibiting Substance is an ovarian growth factor of emerging clinical significance. , 2007, Fertility and sterility.

[10]  A. Volpe,et al.  The Anti-Mullerian hormone and ovarian cancer. , 2007, Human reproduction update.

[11]  A. Volpe,et al.  Serum anti-Mullerian hormone throughout the human menstrual cycle. , 2006, Human reproduction.

[12]  F. Broekmans,et al.  Anti-Müllerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation. , 2006, The Journal of clinical endocrinology and metabolism.

[13]  J. Habbema,et al.  Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study. , 2005, Fertility and sterility.

[14]  F. Broekmans,et al.  Anti-müllerian hormone is a promising predictor for the occurrence of the menopausal transition , 2004, Menopause.

[15]  A. Lass.  Assessment of ovarian reserve: is there still a role for ovarian biopsy in the light of new data? , 2004, Human reproduction.

[16]  B. Fauser,et al.  Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. , 2004, Molecular human reproduction.

[17]  M. Soules,et al.  Reproductive aging and variability in the ovarian antral follicle count: application in the clinical setting. , 2003, Fertility and sterility.

[18]  A. Nyboe Andersen,et al.  Density and distribution of primordial follicles in single pieces of cortex from 21 patients and in individual pieces of cortex from three entire human ovaries. , 2003, Human reproduction.

[19]  P. Pearson,et al.  The variability of female reproductive ageing. , 2002, Human reproduction update.

[20]  B. Fauser,et al.  Antimüllerian hormone serum levels: a putative marker for ovarian aging. , 2002, Fertility and sterility.

[21]  M. Matzuk,et al.  Anti-Müllerian Hormone Attenuates the Effects of FSH on Follicle Development in the Mouse Ovary. , 2001, Endocrinology.

[22]  B. Fauser,et al.  Follicle-stimulating hormone and advanced follicle development in the human. , 2001, Archives of medical research.

[23]  A. Gougeon.  Regulation of ovarian follicular development in primates: facts and hypotheses. , 1996, Endocrine reviews.

[24]  P. Kramer,et al.  Anti-müllerian hormone and anti-müllerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth. , 1995, Endocrinology.

[25]  M. Faddy,et al.  Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. , 1992, Human reproduction.

[26]  P. Donahoe,et al.  Müllerian inhibiting substance as oocyte meiosis inhibitor , 1986, Molecular and Cellular Endocrinology.

[27]  N. Knowlton,et al.  Correlation of ovarian reserve tests with histologically determined primordial follicle number. , 2011, Fertility and sterility.

[28]  Erasmus Mc.  Anti-Müllerian hormone inhibits initiation of growth of human primordial ovarian follicles in vitro , 2006 .

[29]  A. Durlinger,et al.  Anti-Müllerian hormone inhibits initiation of primordial follicle growth in the mouse ovary. , 2002, Endocrinology.